Package 64764-108-21

Brand: entyvio pen

Generic: vedolizumab
NDC Package

Package Facts

Identity

Package NDC 64764-108-21
Digits Only 6476410821
Product NDC 64764-108
Product ID 64764-108_237a0f67-fafa-46ad-a64c-d3209d21cba7
Description

1 TRAY in 1 CARTON (64764-108-21) / 1 SYRINGE in 1 TRAY (64764-108-20) / .68 mL in 1 SYRINGE

Marketing

Marketing Status
Marketed Since 2023-09-27
Brand entyvio pen
Generic vedolizumab
Sample Package No

Linked Drug Pages (1)

ENTYVIO, ENTYVIO Pen, Entyvio ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "237a0f67-fafa-46ad-a64c-d3209d21cba7", "openfda": {"nui": ["N0000175775", "N0000175774"], "unii": ["9RV78Q2002"], "rxcui": ["1538137", "1538142", "2667332", "2667336", "2667339", "2667342"], "spl_set_id": ["6e94621c-1a95-4af9-98d1-52b9e6f1949c"], "pharm_class_epc": ["Integrin Receptor Antagonist [EPC]"], "pharm_class_moa": ["Integrin Receptor Antagonists [MoA]"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TRAY in 1 CARTON (64764-108-21)  / 1 SYRINGE in 1 TRAY (64764-108-20)  / .68 mL in 1 SYRINGE", "package_ndc": "64764-108-21", "marketing_start_date": "20230927"}], "brand_name": "ENTYVIO Pen", "product_id": "64764-108_237a0f67-fafa-46ad-a64c-d3209d21cba7", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Integrin Receptor Antagonist [EPC]", "Integrin Receptor Antagonists [MoA]"], "product_ndc": "64764-108", "generic_name": "vedolizumab", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ENTYVIO Pen", "active_ingredients": [{"name": "VEDOLIZUMAB", "strength": "108 mg/.68mL"}], "application_number": "BLA761133", "marketing_category": "BLA", "marketing_start_date": "20230927", "listing_expiration_date": "20271231"}